BC Advantage - 2017 Issue 7

USE Code: XW0DX82

Biomedical Pharmaceutical Development; it's a risky business: The majority of drugs that begin phase 1 won't be approved, and years of research have shown failures in phase 3, have cost hundreds of millions of dollars per case. Of course, these failures can stem from problems with the studies, but often, failures in the lab are simply part of the trial-and-error nature of pharmaceutical and biotech research. According to FierceBioTech, 17% - 42% is spent on Research & Development alone. Then, there's contrast research, fellows and military physician education, clinical awareness, administrative and the patient education expenses involved. Developing a...

To read the full article, sign in and subscribe to BC Advantage.

Access to this feature is available in the following products:
  • BC Advantage, 30+ CEUs & Webinars

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.